R & d- medical: biomedical (basic research)
Ended Awarded Last action
- Contract number
- HHSN26100004
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $922,642
Award facts
- Opportunity
-
- N01CN201500036 Solicitation number
- Contract value 100% obligated
- $922,642.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $922,642 |
About this award
This is a Firm Fixed Price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to the University of Alabama at Birmingham (UAB) under the PREVENT Cancer Program (PREVENT) indefinite delivery contract. The contract has a ceiling value of $922,642.00 and no set-aside designation.
The contract describes a research and development project in the area of biomedical basic research for the Preclinical Prevention Cancer Program. The work involves conducting preliminary studies to determine the most effective regimen of a non-steroidal anti-inflammatory drug (NSAID) alone or with vaccination for eliciting preventive efficacy and anti-cancer immune responses in an animal model of colorectal cancer. The contract also includes an option to implement additional studies using another NSAID with or without a multi-antigen vaccine in two colorectal cancer models.
As a subcontractor under this contract, the University of Washington will contribute research services related to the experimental design, assessment of preventive efficacy, and evaluation of anti-cancer immune responses.
Quick answers
Who was awarded contract HHSN26100004?
HHSN26100004 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on September 20, 2016.
How much is contract HHSN26100004 worth?
The government has obligated $922,642 on HHSN26100004.
Is contract HHSN26100004 an order under another contract?
Yes. HHSN26100004 is a delivery order under HHSN261201500036I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100004 competed?
The extent of competition for HHSN26100004 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award